Improving the EMA Binding Test by Using Commercially Available Fluorescent Beads.

Area of Science:

• Hematology
• Clinical Diagnostics
• Biochemistry

Background:

• Hereditary spherocytosis (HS) is a prevalent inherited anemia.
• HS results from mutations in red blood cell cytoskeleton proteins.
• Current diagnostics, like the eosin-5'-maleimide (EMA) binding test, require healthy controls, complicating comparisons.

Purpose of the Study:

• To develop and validate a modified EMA binding test for HS diagnosis.
• To replace healthy controls with fluorescent beads in the EMA test.
• To assess the feasibility of the modified test for interlaboratory standardization.

Main Methods:

• A modified EMA binding test utilizing fluorescent beads instead of healthy controls was developed.
• 289 suspected HS patient samples were analyzed using both the modified and standard EMA tests.
• Osmotic gradient ektacytometry served as the validation method.

Main Results:

• The modified EMA test achieved 90.3% accuracy, comparable to the standard test's 88.6% accuracy.
• 112 individuals (38.8%) were diagnosed with HS.
• The modified test demonstrated high performance without compromising diagnostic reliability.

Conclusions:

• The modified EMA binding test with fluorescent beads is a viable alternative for HS diagnosis.
• This approach enhances diagnostic accessibility, particularly for labs lacking matched controls.
• Fluorescent beads offer stability and commutability, supporting interlaboratory comparisons and quality assessment.